Bausch Health Companies Inc Stock Toronto S.E.
Equities
CA91911K1021
Pharmaceuticals
Sales 2024 * | 9.38B 12.84B | Sales 2025 * | 9.64B 13.19B | Capitalization | 2.97B 4.06B |
---|---|---|---|---|---|
Net income 2024 * | 240M 328M | Net income 2025 * | 389M 532M | EV / Sales 2024 * | 2.49 x |
Net Debt 2024 * | 20.44B 27.96B | Net Debt 2025 * | 19.09B 26.12B | EV / Sales 2025 * | 2.29 x |
P/E ratio 2024 * |
15.9
x | P/E ratio 2025 * |
7.68
x | Employees | - |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 97.66% |
Latest transcript on Bausch Health Companies Inc
Managers | Title | Age | Since |
---|---|---|---|
Thomas Appio
CEO | Chief Executive Officer | 61 | - |
John Barresi
DFI | Director of Finance/CFO | 51 | 22-05-23 |
Chief Operating Officer | - | - |
Members of the board | Title | Age | Since |
---|---|---|---|
Robert Power
BRD | Director/Board Member | 67 | 08-07-31 |
John Paulson
CHM | Chairman | 68 | 17-05-31 |
Steven Miller
BRD | Director/Board Member | 35 | 21-03-16 |
1st Jan change | Capi. | |
---|---|---|
+26.08% | 681B | |
+21.85% | 556B | |
-4.77% | 361B | |
+16.97% | 325B | |
+5.69% | 285B | |
+13.68% | 235B | |
+3.65% | 199B | |
-11.12% | 189B | |
-3.40% | 157B |